AU2019903735A0 - Dyes and methods of use - Google Patents

Dyes and methods of use

Info

Publication number
AU2019903735A0
AU2019903735A0 AU2019903735A AU2019903735A AU2019903735A0 AU 2019903735 A0 AU2019903735 A0 AU 2019903735A0 AU 2019903735 A AU2019903735 A AU 2019903735A AU 2019903735 A AU2019903735 A AU 2019903735A AU 2019903735 A0 AU2019903735 A0 AU 2019903735A0
Authority
AU
Australia
Prior art keywords
dyes
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019903735A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
Original Assignee
University of Queensland UQ
Filing date
Publication date
Application filed by University of Queensland UQ filed Critical University of Queensland UQ
Publication of AU2019903735A0 publication Critical patent/AU2019903735A0/en
Priority to PCT/AU2020/051068 priority Critical patent/WO2021062491A1/en
Abandoned legal-status Critical Current

Links

AU2019903735A 2019-10-04 2019-10-04 Dyes and methods of use Abandoned AU2019903735A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2020/051068 WO2021062491A1 (en) 2019-10-04 2020-10-02 Cibalackrot red dye compounds and methods of use in organic solid-state lasers and opto-electronic applications

Publications (1)

Publication Number Publication Date
AU2019903735A0 true AU2019903735A0 (en) 2019-10-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP4031177A4 (en) Anti-tnfr2 antibodies and methods of use
EP3852805A4 (en) Anti-lilrb2 antibodies and methods of use thereof
EP3810617A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3962481A4 (en) Kcnt1 inhibitors and methods of use
EP3962479A4 (en) Kcnt1 inhibitors and methods of use
EP3752166A4 (en) Trialkyne linking agents and methods of use
EP3972991A4 (en) Nr4a super-repressors and methods of use thereof
EP3886853A4 (en) Diarylhydantoin compounds and methods of use thereof
EP3983386A4 (en) Acss2 inhibitors and methods of use thereof
EP3829307A4 (en) Bismuth-thiol compositions and methods of use
EP3986894A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3930756A4 (en) Lilrb4-binding antibody and methods of use thereof
EP3846808A4 (en) Papd5 inhibitors and methods of use thereof
EP4037715A4 (en) Protein-macromolecule conjugates and methods of use thereof
EP3969460A4 (en) Ascaroside derivatives and methods of use
EP4009777A4 (en) Transcription factor nterf221 and methods of using the same
EP3959197A4 (en) Papd5 inhibitors and methods of use thereof
EP3765485A4 (en) Immuno-exosomes and methods of use thereof
EP3761989A4 (en) Imidazodiazepinediones and methods of use thereof
EP3746484A4 (en) Anti-ms4a6a antibodies and methods of use thereof
EP4038139A4 (en) Adhesive and methods of use
EP4031144A4 (en) Benzimidazoles and methods of using same
EP3941909A4 (en) Pi4-kinase inhibitors and methods of using the same
EP3843555A4 (en) Anthocyanin-based colorant compositions and methods of use thereof
EP3813821A4 (en) Methods and uses of colchicine derivatives